Boland BS - Search Results

1

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.

Dulai PS, Singh S, Vande Casteele N, Meserve J, Winters A, Chablaney S, Aniwan S, Shashi P, Kochhar G, Weiss A, Koliani-Pace JL, Gao Y, Boland BS, Chang JT, Faleck D, Hirten R, Ungaro R, Lukin D, Sultan K, Hudesman D, Chang S, Bohm M, Varma S, Fischer M, Shmidt E, Swaminath A, Gupta N, Rosario M, Jairath V, Guizzetti L, Feagan BG, Siegel CA, Shen B, Kane S, Loftus EV Jr, Sandborn WJ, Sands BE, Colombel JF, Lasch K, Cao C. Dulai PS, et al. Among authors: boland bs. Clin Gastroenterol Hepatol. 2020 Dec;18(13):2952-2961.e8. doi: 10.1016/j.cgh.2020.02.010. Epub 2020 Feb 13. Clin Gastroenterol Hepatol. 2020. PMID: 32062041 Free PMC article.

2

Non-cirrhotic portal hypertension due to 6-mercaptopurine use for Crohn's disease.

Pola S, Boland BS, Lin GY, Kuo A, Sandborn WJ. Pola S, et al. Among authors: boland bs. Dig Dis Sci. 2014 Jul;59(7):1642-4. doi: 10.1007/s10620-014-3052-3. Epub 2014 Feb 18. Dig Dis Sci. 2014. PMID: 24535249 Free PMC article. No abstract available.

3

Validated gene expression biomarker analysis for biopsy-based clinical trials in ulcerative colitis.

Boland BS, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Chang JT. Boland BS, et al. Aliment Pharmacol Ther. 2014 Sep;40(5):477-85. doi: 10.1111/apt.12862. Epub 2014 Jul 13. Aliment Pharmacol Ther. 2014. PMID: 25041724 Free PMC article.

4

Update on Janus kinase antagonists in inflammatory bowel disease.

Boland BS, Sandborn WJ, Chang JT. Boland BS, et al. Gastroenterol Clin North Am. 2014 Sep;43(3):603-17. doi: 10.1016/j.gtc.2014.05.011. Epub 2014 Jun 24. Gastroenterol Clin North Am. 2014. PMID: 25110261 Free PMC article. Review.

5

Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease.

Boland BS, Boyle DL, Sandborn WJ, Firestein GS, Levesque BG, Hillman J, Zhang B, Proudfoot J, Eckmann L, Ernst PB, Rivera-Nieves J, Pola S, Copur-Dahi N, Zou G, Chang JT. Boland BS, et al. Inflamm Bowel Dis. 2015 Feb;21(2):323-30. doi: 10.1097/MIB.0000000000000264. Inflamm Bowel Dis. 2015. PMID: 25545378 Free PMC article.

6

Pseudomonas Meningitis During Vedolizumab Therapy for Crohn's Disease.

Boland BS, Dulai PS, Chang M, Sandborn WJ, Levesque BG. Boland BS, et al. Am J Gastroenterol. 2015 Nov;110(11):1631-2. doi: 10.1038/ajg.2015.326. Am J Gastroenterol. 2015. PMID: 26618431 Free PMC article. No abstract available.

7

How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.

Dulai PS, Singh S, Casteele NV, Boland BS, Sandborn WJ. Dulai PS, et al. Among authors: boland bs. Inflamm Bowel Dis. 2016 Apr;22(4):998-1009. doi: 10.1097/MIB.0000000000000661. Inflamm Bowel Dis. 2016. PMID: 26835982 Free PMC article. Review.

8

Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

Boland BS, Bagi P, Valasek MA, Chang JT, Bustamante R, Madlensky L, Sandborn WJ, Harismendy O, Gupta S. Boland BS, et al. Am J Gastroenterol. 2016 May;111(5):746-8. doi: 10.1038/ajg.2016.92. Am J Gastroenterol. 2016. PMID: 27151126 Free PMC article. No abstract available.

9

The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY Consortium.

Dulai PS, Singh S, Jiang X, Peerani F, Narula N, Chaudrey K, Whitehead D, Hudesman D, Lukin D, Swaminath A, Shmidt E, Wang S, Boland BS, Chang JT, Kane S, Siegel CA, Loftus EV, Sandborn WJ, Sands BE, Colombel JF. Dulai PS, et al. Among authors: boland bs. Am J Gastroenterol. 2016 Aug;111(8):1147-55. doi: 10.1038/ajg.2016.236. Epub 2016 Jun 14. Am J Gastroenterol. 2016. PMID: 27296941

10

Vedolizumab in Patients With Common Variable Immune Deficiency and Gut Inflammation.

Boland BS, Riedl MA, Valasek MA, Crowe SE, Sandborn WJ. Boland BS, et al. Am J Gastroenterol. 2017 Oct;112(10):1621. doi: 10.1038/ajg.2017.246. Am J Gastroenterol. 2017. PMID: 28978958 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page